medicalxpress.com
New research reveals the mechanisms by which SARS-CoV-2, the virus responsible for COVID-19, harms blood vessels and the heart, increasing cardiovascular risk.
Understanding the cardiovascular implications of COVID-19 is crucial for healthcare providers to manage and mitigate long-term health risks in patients affected by the virus.
SARS-CoV-2, the virus responsible for COVID-19, impacts cardiovascular health by damaging blood vessels and heart muscle. Research highlights the virus's ability to trigger an excessive immune response, leading to inflammation and increased risk of heart attacks and strokes. The virus infiltrates cells via ACE2 receptors and disrupts mitochondrial function, spurring immune overreaction. Autopsy studies show viral presence in macrophages within the heart, emphasizing the ongoing need to monitor cardiovascular risks in COVID-19 patients.
SARS-CoV-2 uses ACE2 receptors to enter host cells, which are abundant in both lung and cardiovascular systems.
SARS-CoV-2 enters host cells utilizing ACE2 receptors, which are crucial to cardiovascular function.
The abundance of ACE2 receptors in cells throughout the respiratory and cardiovascular systems facilitates viral entry and replication, affecting heart health.
SARS-CoV-2 is a large, enveloped RNA virus that enters the human body primarily through the respiratory system, targeting cells rich in ACE2 receptors. These receptors are not only located in the lungs but are also prevalent in cardiovascular tissues.
"Cells in the lungs and blood vessels contain an abundance of ACE2 receptors," noted Dr. DeLisa Fairweather from the Mayo Clinic. "These receptors are crucial both for viral entry and cardiovascular regulation."
The virus infiltrates these cells using a spike protein, beginning with areas including the respiratory tract and potentially spreading to the cardiovascular system, leading to inflammation and further complications.
SARS-CoV-2 triggers an exaggerated immune response, escalating inflammation within the cardiovascular system.
The body's immune response to SARS-CoV-2 can cause significant inflammation in blood vessels and heart tissue.
Excessive immune reactions can exacerbate cardiovascular issues, including atherosclerosis and myocarditis.
Once inside the cells, SARS-CoV-2 hijacks host cellular machinery, notably targeting mitochondria, leading to energy depletion. This attack on mitochondria triggers an exaggerated immune response known as a cytokine storm.
"We die without mitochondria," Dr. Fairweather explained. "So this sends out a big alarm to the rest of the body," leading to extreme inflammation.
This heightened inflammatory state can exacerbate conditions like atherosclerosis, where plaque buildup in the arteries is aggravated, increasing the risk of cardiovascular events such as heart attacks and strokes.
The risk of heart attacks and strokes remains elevated for years following SARS-CoV-2 infection.
Individuals with COVID-19 may face long-lasting cardiovascular risks due to persistent inflammation and immune dysregulation.
Research indicates that the inflammatory effects of SARS-CoV-2 can trigger long-term cardiovascular complications.
Studies have shown that the inflammatory response induced by SARS-CoV-2 can continue to affect cardiovascular health long after the initial infection has resolved. This persistent risk is highlighted by findings of increased heart attack and stroke incidence over subsequent years.
"This is what creates heart attacks and strokes," Dr. Chiara Giannarelli stated, emphasizing the long-term impact of viral-triggered inflammation.
Ongoing monitoring and management of cardiovascular health are recommended for individuals recovering from COVID-19 to address these long-term risks, particularly in those with pre-existing conditions or who experienced severe symptoms during infection.